September is recognized in the U.S. as Blood Cancer Awareness Month, a period dedicated to increasing awareness of leukemia, lymphoma, myeloma and the ...
Reckitt has announced on September 16, 2026 up to $600 million in a multi-year transformation of its U.S. operations, with a major share of that ...
Novo Nordisk and Anthropic announced a collaboration on September 16, 2026 aimed at helping Novo accelerate the development ...
The U.S. Food and Drug Administration issued a direct final rule on September 21, 2026 that updates its regulations to ...
Merck, known as MSD outside the U.S. and Canada, launched Your Hive of Whole Health on September 18, 2026 — a multi-year ...
Scientists, industry professionals, economic-development leaders, and community partners gathered September 9, at Matan at ...
Rachel Chiaverelli, PhD, has joined GSK as Executive Director, Oncology Early Translational Biomarkers, after nearly four ...
OS Therapies Aligns With FDA on Phase 3 Design, Accepts MHRA’s Project Orbis Invitation for OST-HER2
OS Therapies, Inc., a Rockville, Maryland- and New York-based clinical-stage oncology company, announced on September 17, ...
Jonathan E. Burke, D.M.D., has been selected to serve as Director of the National Institute of Dental and Craniofacial ...
Edwin Beale has been named Chief Commercial Officer of Kincellis Advanced Therapies, the cell therapy CDMO formed this month ...
GBI Bio has named Jesse McCool, PhD, as Chief Executive Officer, effective September 8, 2026. “Since joining GBI, Jesse has ...
Lineberger Comprehensive Cancer Center has received $40 million from the OpenAI Foundation — the nonprofit parent ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results